Drug
Mineral Sunshield Universal Tint Broad Spectrum Spf 30 Sunscreen
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Macular Degeneration | 460 | 433.9 | 568.4 | signal |
| 2 | Vaginal Discharge | 147 | 160.4 | 173.5 | signal |
| 3 | Paraesthesia Oral | 198 | 150.9 | 167.9 | signal |
| 4 | Oral Candidiasis | 148 | 124.3 | 134.5 | signal |
| 5 | Procedural Pain | 190 | 74.7 | 82.7 | signal |
| 6 | Frequent Bowel Movements | 152 | 61.4 | 66.5 | signal |
| 7 | Colitis | 150 | 43.2 | 46.7 | signal |
| 8 | Rectal Haemorrhage | 162 | 40.7 | 44.4 | signal |
| 9 | Colitis Ulcerative | 151 | 36.7 | 39.7 | signal |
| 10 | Infusion Related Reaction | 201 | 33.0 | 36.7 | signal |
| 11 | Therapeutic Product Effect Incomplete | 214 | 32.8 | 36.7 | signal |
| 12 | Accident | 36 | 32.8 | 33.4 | signal |
| 13 | Haematochezia | 158 | 31.1 | 33.7 | signal |
| 14 | Nephropathy | 24 | 27.7 | 28.0 | signal |
| 15 | Body Height Decreased | 24 | 24.0 | 24.3 | signal |
| 16 | Haemorrhoids | 42 | 23.3 | 23.8 | signal |
| 17 | Dyspepsia | 197 | 21.7 | 24.1 | signal |
| 18 | Body Temperature Increased | 39 | 20.6 | 21.0 | signal |
| 19 | Schizophrenia | 22 | 19.6 | 19.8 | signal |
| 20 | Obesity | 28 | 19.0 | 19.3 | signal |
| 21 | Joint Range Of Motion Decreased | 23 | 18.6 | 18.8 | signal |
| 22 | Sciatica | 27 | 18.4 | 18.7 | signal |
| 23 | Cholelithiasis | 47 | 15.5 | 15.9 | signal |
| 24 | Hepatic Steatosis | 26 | 15.1 | 15.3 | signal |
| 25 | Foot Deformity | 15 | 14.6 | 14.7 | signal |
| 26 | Synovitis | 24 | 14.4 | 14.6 | signal |
| 27 | Hepatotoxicity | 27 | 13.2 | 13.3 | signal |
| 28 | Knee Arthroplasty | 24 | 12.4 | 12.6 | signal |
| 29 | Febrile Neutropenia | 72 | 11.8 | 12.2 | signal |
| 30 | Limb Injury | 28 | 11.2 | 11.3 | signal |
| 31 | Bacteraemia | 12 | 11.0 | 11.1 | signal |
| 32 | Blood Bilirubin Increased | 27 | 10.8 | 10.9 | signal |
| 33 | Joint Stiffness | 26 | 10.7 | 10.8 | signal |
| 34 | Anaemia | 187 | 10.6 | 11.6 | signal |
| 35 | Arthropathy | 54 | 10.5 | 10.7 | signal |
| 36 | Pneumonia Aspiration | 24 | 10.4 | 10.5 | signal |
| 37 | Dysstasia | 27 | 10.0 | 10.1 | signal |
| 38 | Constipation | 194 | 9.7 | 10.7 | signal |
| 39 | Pyrexia | 306 | 9.6 | 11.2 | signal |
| 40 | Arteriosclerosis | 8 | 9.2 | 9.2 | signal |
| 41 | Clostridium Difficile Colitis | 9 | 9.2 | 9.2 | signal |
| 42 | Weight Decreased | 236 | 9.1 | 10.3 | signal |
| 43 | Erythema | 169 | 8.9 | 9.7 | signal |
| 44 | Movement Disorder | 26 | 8.7 | 8.8 | signal |
| 45 | Abdominal Pain | 187 | 8.7 | 9.5 | signal |
| 46 | Hepatic Enzyme Increased | 54 | 8.6 | 8.8 | signal |
| 47 | Lower Respiratory Tract Infection | 33 | 7.9 | 8.0 | signal |
| 48 | Bone Density Decreased | 23 | 7.8 | 7.9 | signal |
| 49 | Skin Disorder | 24 | 7.8 | 7.9 | signal |
| 50 | Malnutrition | 8 | 7.8 | 7.8 | signal |
| 51 | Psychotic Disorder | 21 | 7.7 | 7.8 | signal |
| 52 | Osteoporosis | 29 | 7.6 | 7.7 | signal |
| 53 | Psoriatic Arthropathy | 28 | 7.5 | 7.6 | signal |
| 54 | Osteoarthritis | 29 | 7.4 | 7.5 | signal |
| 55 | Lymphocyte Count Decreased | 12 | 7.3 | 7.4 | signal |
| 56 | Disseminated Intravascular Coagulation | 9 | 6.9 | 6.9 | signal |
| 57 | Cytokine Release Syndrome | 12 | 6.8 | 6.8 | signal |
| 58 | Drug Eruption | 11 | 6.7 | 6.8 | signal |
| 59 | Malaise | 261 | 6.4 | 7.3 | signal |
| 60 | Respiratory Distress | 16 | 6.3 | 6.3 | signal |
| 61 | Dermatitis | 12 | 6.3 | 6.3 | signal |
| 62 | Incontinence | 6 | 6.1 | 6.1 | signal |
| 63 | Liver Disorder | 25 | 6.1 | 6.2 | signal |
| 64 | Obstructive Airways Disorder | 6 | 5.8 | 5.8 | signal |
| 65 | Oral Pain | 12 | 5.8 | 5.8 | signal |
| 66 | Lung Neoplasm Malignant | 22 | 5.8 | 5.8 | signal |
| 67 | Therapy Partial Responder | 8 | 5.7 | 5.8 | signal |
| 68 | Musculoskeletal Pain | 28 | 5.7 | 5.8 | signal |
| 69 | Device Related Infection | 8 | 5.6 | 5.6 | signal |
| 70 | Chronic Obstructive Pulmonary Disease | 27 | 5.6 | 5.7 | signal |
| 71 | Blood Lactate Dehydrogenase Increased | 8 | 5.4 | 5.4 | signal |
| 72 | Transfusion | 5 | 5.1 | 5.1 | signal |
| 73 | Neutropenia | 63 | 5.0 | 5.2 | signal |
| 74 | Mucosal Inflammation | 12 | 5.0 | 5.0 | signal |
| 75 | Pain | 282 | 5.0 | 5.6 | signal |
| 76 | Bedridden | 6 | 4.9 | 5.0 | signal |
| 77 | Gastrointestinal Pain | 5 | 4.9 | 4.9 | signal |
| 78 | Product Administration Error | 9 | 4.9 | 4.9 | signal |
| 79 | Red Blood Cell Sedimentation Rate Increased | 5 | 4.9 | 4.9 | signal |
| 80 | Diabetes Mellitus | 34 | 4.8 | 4.9 | signal |
| 81 | Scab | 5 | 4.8 | 4.8 | signal |
| 82 | Metastases To Bone | 7 | 4.6 | 4.6 | signal |
| 83 | Proteinuria | 8 | 4.6 | 4.6 | signal |
| 84 | Covid-19 Pneumonia | 5 | 4.5 | 4.6 | signal |
| 85 | Posterior Reversible Encephalopathy Syndrome | 4 | 4.5 | 4.5 | signal |
| 86 | Blood Urine Present | 8 | 4.5 | 4.6 | signal |
| 87 | Subdural Haematoma | 6 | 4.5 | 4.5 | signal |
| 88 | Intentional Product Misuse | 35 | 4.4 | 4.4 | signal |
| 89 | Tooth Extraction | 5 | 4.3 | 4.3 | signal |
| 90 | Hypothermia | 4 | 4.3 | 4.3 | signal |
| 91 | Sluggishness | 4 | 4.3 | 4.3 | signal |
| 92 | Poor Venous Access | 4 | 4.2 | 4.2 | signal |
| 93 | Herpes Zoster | 22 | 4.1 | 4.2 | signal |
| 94 | Skin Fissures | 7 | 4.0 | 4.0 | signal |
| 95 | Internal Haemorrhage | 4 | 3.8 | 3.8 | signal |
| 96 | Drug Abuse | 29 | 3.7 | 3.8 | signal |
| 97 | Dementia | 9 | 3.5 | 3.5 | signal |
| 98 | Muscle Spasticity | 4 | 3.5 | 3.5 | signal |
| 99 | Deformity | 3 | 3.5 | 3.5 | no signal |
| 100 | Anaphylactic Shock | 8 | 3.4 | 3.4 | signal |
| 101 | Thrombotic Microangiopathy | 3 | 3.3 | 3.3 | no signal |
| 102 | Pneumocystis Jirovecii Pneumonia | 3 | 3.2 | 3.2 | no signal |
| 103 | Toxic Skin Eruption | 3 | 3.2 | 3.2 | no signal |
| 104 | Pain Of Skin | 8 | 3.2 | 3.2 | signal |
| 105 | Bone Marrow Failure | 6 | 3.2 | 3.2 | signal |
| 106 | Serotonin Syndrome | 5 | 2.8 | 2.8 | signal |
| 107 | Psoriasis | 33 | 2.7 | 2.8 | signal |
| 108 | Osteonecrosis Of Jaw | 6 | 2.6 | 2.6 | signal |
| 109 | Amenorrhoea | 4 | 2.6 | 2.6 | no signal |
| 110 | Device Failure | 3 | 2.1 | 2.1 | no signal |
| 111 | Application Site Pain | 4 | 2.0 | 2.0 | no signal |
| 112 | Drug Dependence | 26 | 1.7 | 1.7 | no signal |
| 113 | Injection Site Mass | 5 | 1.5 | 1.5 | no signal |
| 114 | Myelosuppression | 4 | 1.3 | 1.3 | no signal |
| 115 | Device Leakage | 4 | 1.0 | 1.0 | no signal |